NO20064007L - Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover - Google Patents
Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnoverInfo
- Publication number
- NO20064007L NO20064007L NO20064007A NO20064007A NO20064007L NO 20064007 L NO20064007 L NO 20064007L NO 20064007 A NO20064007 A NO 20064007A NO 20064007 A NO20064007 A NO 20064007A NO 20064007 L NO20064007 L NO 20064007L
- Authority
- NO
- Norway
- Prior art keywords
- preventing
- individuals
- bone turnover
- procedure
- treating osteoporosis
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 230000008416 bone turnover Effects 0.000 title abstract 2
- 229940095743 selective estrogen receptor modulator Drugs 0.000 abstract 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 abstract 2
- 229960003969 ospemifene Drugs 0.000 abstract 1
- LUMKNAVTFCDUIE-VHXPQNKSSA-N ospemifene Chemical compound C1=CC(OCCO)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 LUMKNAVTFCDUIE-VHXPQNKSSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/783,092 US20050187302A1 (en) | 2004-02-23 | 2004-02-23 | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
| PCT/FI2005/000034 WO2005079776A1 (en) | 2004-02-23 | 2005-01-19 | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20064007L true NO20064007L (no) | 2006-09-21 |
Family
ID=34861145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20064007A NO20064007L (no) | 2004-02-23 | 2006-09-06 | Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050187302A1 (pt) |
| EP (1) | EP1718287A1 (pt) |
| JP (1) | JP2007523209A (pt) |
| CN (1) | CN1972680A (pt) |
| AU (1) | AU2005215173A1 (pt) |
| BR (1) | BRPI0507912A (pt) |
| CA (1) | CA2557116A1 (pt) |
| MX (1) | MXPA06009549A (pt) |
| NO (1) | NO20064007L (pt) |
| RU (1) | RU2006133903A (pt) |
| WO (1) | WO2005079776A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8236861B2 (en) * | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
| US20080171319A1 (en) * | 2006-02-06 | 2008-07-17 | Mickey Urdea | Osteoporosis associated markers and methods of use thereof |
| WO2008099060A2 (en) * | 2007-02-14 | 2008-08-21 | Hormos Medical Ltd | Methods for the preparation of fispemifene from ospemifene |
| PL2121553T3 (pl) * | 2007-02-14 | 2012-11-30 | Hormos Medical Ltd | Sposób wytwarzania cennych terapeutycznie pochodnych trifenylobutenu |
| EP2225559B8 (en) * | 2007-12-28 | 2016-12-21 | F. Hoffmann-La Roche AG | Assessment of physiological conditions |
| CN102690347B (zh) * | 2012-05-18 | 2014-06-25 | 北京北方生物技术研究所 | 分离i型前胶原氨基末端肽的方法 |
| US9321712B2 (en) | 2012-10-19 | 2016-04-26 | Fermion Oy | Process for the preparation of ospemifene |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9418067D0 (en) * | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
-
2004
- 2004-02-23 US US10/783,092 patent/US20050187302A1/en not_active Abandoned
-
2005
- 2005-01-19 MX MXPA06009549A patent/MXPA06009549A/es unknown
- 2005-01-19 JP JP2007500232A patent/JP2007523209A/ja not_active Abandoned
- 2005-01-19 CN CNA2005800049712A patent/CN1972680A/zh active Pending
- 2005-01-19 EP EP05708122A patent/EP1718287A1/en not_active Ceased
- 2005-01-19 RU RU2006133903/14A patent/RU2006133903A/ru not_active Application Discontinuation
- 2005-01-19 WO PCT/FI2005/000034 patent/WO2005079776A1/en not_active Ceased
- 2005-01-19 AU AU2005215173A patent/AU2005215173A1/en not_active Abandoned
- 2005-01-19 BR BRPI0507912-8A patent/BRPI0507912A/pt not_active IP Right Cessation
- 2005-01-19 CA CA002557116A patent/CA2557116A1/en not_active Abandoned
-
2006
- 2006-09-06 NO NO20064007A patent/NO20064007L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1718287A1 (en) | 2006-11-08 |
| JP2007523209A (ja) | 2007-08-16 |
| BRPI0507912A (pt) | 2007-07-10 |
| US20050187302A1 (en) | 2005-08-25 |
| AU2005215173A1 (en) | 2005-09-01 |
| WO2005079776A1 (en) | 2005-09-01 |
| CA2557116A1 (en) | 2005-09-01 |
| MXPA06009549A (es) | 2007-04-10 |
| CN1972680A (zh) | 2007-05-30 |
| RU2006133903A (ru) | 2008-03-27 |
| AU2005215173A8 (en) | 2009-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072863L (no) | Fremgangsmate til a rense FSH | |
| WO2005117870A3 (en) | Combination of proton pump inhibitor, buffering agent, and prokinetic agent | |
| NO20071090L (no) | Behandling av pulmonal hypertensjon ved inhalert iloprost med en mikropartikkelformulering. | |
| TW200627594A (en) | A method to form a passivation layer | |
| NO20070910L (no) | Pyrrolderivater som farmasoytiske middel | |
| TW200614075A (en) | Method for operating instruction, processor, multiple-processor system, and machine-readable medium | |
| NO20092612L (no) | Forbindelser og metode for kinasemodulering og indikasjoner for dette | |
| WO2006048777A3 (en) | Modified growth hormones | |
| EP1810172A4 (en) | METHOD AND SYSTEM FOR DELIVERING CONTENT TO USERS BASED ON INTERACTION FREQUENCY | |
| NO20065211L (no) | Multibaerebolgekommunikasjon | |
| SG116667A1 (en) | Internal riser inspection system, apparatus and methods of using same. | |
| NO20073628L (no) | Pyridoner som er nyttige som inhibitorer av kinaser | |
| TW200604775A (en) | Apparatus, system, and method for protecting digital content | |
| NO20082170L (no) | Forbedret testosterongel og fremgangsmate til anvendelse | |
| NO20044562L (no) | Fremgangsmater for behandling av tarmslyng | |
| BRPI0821764A8 (pt) | Método de alinhamento de sincronismo de enlace ascendente em equipamento de usuário | |
| NO20064007L (no) | Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover | |
| GEP20135800B (en) | Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation | |
| NO20053111L (no) | Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. | |
| MY148863A (en) | Hexahydro-cyclooctyl pyrazole cannabinoid modulators | |
| AU2003283217A8 (en) | Method for determing predisposition to manifestation of immune system related diseases | |
| NO20055187L (no) | Fremgangsmate for behandling og forebygging av lavere urinkanal symptomer | |
| ZA200803532B (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| NO20051432D0 (no) | Komposittplate for ortopediteknikken, fremgangsmate til dens fremstilling og dens anvendelse | |
| WO2003094967A3 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |